Pharmacological Treatment of Presbyopia Using Pilocarpine 1.25% Eye Drops

Purpose: To assess the efficiency and safety of pilocarpine eye drop 1.25% analogue (IRPilo) in comparison with its original brand-name drug (Vuity). Methods: In this non-randomized comparative study, 75 patients with presbyopia aged 40 to 60 years were enrolled. The right eyes of these patients r...

Full description

Saved in:
Bibliographic Details
Main Authors: Seyed Abolghasem Mousavi, Zhale Rajavi, Hamideh Sabbaghi, Saeid Abdi, Nafeeseh Montazerin, Bahareh Kheiri, Azadeh Haseli- Monfared, Kourosh Sheibani, Hemn Baghban Jaldian
Format: Article
Language:English
Published: Knowledge E 2024-12-01
Series:Journal of Ophthalmic & Vision Research
Subjects:
Online Access:https://knepublishing.com/index.php/JOVR/article/view/14578
Tags: Add Tag
No Tags, Be the first to tag this record!